Neurocognitive Effects of Ketamine in Treatment-Resistant Major Depression: Association with Antidepressant Response

RATIONALE: The N-methyl-d-aspartate (NMDA) glutamate receptor antagonist ketamine has demonstrated rapid antidepressant effects in patients with treatment-resistant depression (TRD). Despite the promise of a novel and urgently needed treatment for refractory depression, concerns regarding potential...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Murrough, James W., Wan, Le-Ben, Iacoviello, Brian, Collins, Katherine A., Solon, Carly, Glicksberg, Benjamin, Perez, Andrew M., Mathew, Sanjay J., Charney, Dennis S., Iosifescu, Dan V., Burdick, Katherine E.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3952038/
https://ncbi.nlm.nih.gov/pubmed/24022236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-013-3255-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki